RNA-based therapeutics have emerged as a revolutionary approach for treating genetic disorders, cancers, and infectious diseases. However, delivering RNA molecules safely and efficiently into target cells remains a major challenge. Three leading delivery platforms—exosomes for RNA delivery, liposomes for RNA delivery, and lipid nanoparticles (LNPs) for RNA delivery—have shown...
Antibody modification and conjugation technologies have emerged as pivotal tools in the field of biopharmaceuticals, enabling the development of more effective therapeutic antibodies. By enhancing the efficacy, stability, and specificity of antibodies, these technologies have facilitated the creation of targeted therapies for various diseases, including cancer and autoimmune disorders....
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)